Sökresultat - "18F-FDG PET/CT"

Activating Human Adipose Tissue with the β 3-Adrenergic Agonist Mirabegron

Chen, Kong Y.^{Aff4, Aff5}, Brychta, Robert J.^{Aff4, Aff5}, Israni, Nikita S.^{Aff4, Aff5}, Jiang, Alex^{Aff4, Aff5}, Lea, Hannah J.^{Aff4, Aff5}, Lentz, Taylor N.^{Aff4, Aff5}, Pierce, Anne E.^{Aff4, Aff5}, Cypess, Aaron M.^{Aff4, Aff5}

Guertin, David A.^Aff2, Wolfrum, Christian^Aff3, Walker, John M.^Aff1

Predictive classification of lung cancer pathological based on PET/CT radiomics

Peng, Mengye, Wang, Menglu, An, Wenxin, Wu, Tingting, Zhang, Ying, Ge, Fan, Cheng, Liang, Liu, Wei, Wang, Kezheng^{Aff1, IDs11604025017424_cor1}

Associations of subclinical microcalcification and inflammation with carotid atheroma development: a dual-tracer PET/CT study

Patil, Shiv^{Aff1, Aff2}, Kata, Rithvik^{Aff1, Aff2}, Teichner, Eric^{Aff1, Aff2}, Subtirelu, Robert, Ghonim, Mohanad^{Aff1, Aff3}, Ghonim, Mohamed^{Aff1, Aff3}, Al-Daoud, Omar, Ismoilov, Miraziz, Herpin, Lancelot, Ayubcha, Cyrus, Werner, Thomas, Høilund-Carlsen, Poul Flemming, Alavi, Abass^{Aff1, IDs0025902507127z_cor1}

Association of PET vascular activity score with Takayasu’s arteritis angiographic progression

Wu, Sifan^Aff1, Wu, Bing^Aff2, Ma, Lingying^Aff1, Li, Mengdi, Sun, Xianting, Zhang, Shuhui, Shi, Hongcheng, Jiang, Lindi^{Aff1, Aff3, IDs00259025073482_cor1}

Quantitative ¹⁸F-FDG PET/CT Model for predicting pathological complete response to neoadjuvant immunochemotherapy in NSCLC: comparison with RECIST 1.1 and PERCIST

Deng, Yueling^{Aff1, Aff2, Aff3}, Zhang, Xiao^{Aff1, Aff2, Aff3}, Hu, Fan^{Aff1, Aff2, Aff3}, Lan, Xiaoli^{Aff1, Aff2, Aff3, IDs00259025073428_cor1}

Post-COVID-19 lung disease: utility of biochemical and imaging markers in uncovering residual lung inflammation and monitoring anti-inflammatory therapy, a prospective study

Khandelwal, Yogita, Ora, Manish, Jain, Bela, Dixit, Manish, Singh, Prakash, Khan, Ajmal, Nath, Alok, Agarwal, Vikas, Gambhir, Sanjay^{Aff2, IDs0025902507297w_cor1}

Molecular imaging using ¹⁸F-FDG PET/CT and circulating inflammatory and immune indicators to predict pathological response to neoadjuvant camrelizumab plus chemotherapy in resectable stage IIIA–IIIB NSCLC

Wang, Kaiyue^{Aff1, Aff2}, Wang, Xiaohan, Meng, Xue^{Aff2, Aff3, IDs12149025020570_cor1}, Zhang, Guodong^{Aff4, IDs12149025020570_cor2}, Cai, Guoxin^{Aff2, IDs12149025020570_cor3}

HER2-targeted PET/CT imaging provides potential biomarkers for differentiating HER2-zero, -low, and -positive breast cancer

Gao, Yuan^{Aff1, Aff2}, Yin, Lei^Aff1, Duan, Xiaojiang, Fu, Zijian, Liu, Qian, Chen, Jinzhi, Xin, Ling, Zhu, Xiaojuan, Xiang, Hongyu, Xu, Ling^{Aff2, IDs00259025072203_cor1}, Ye, Jingming^{Aff2, IDs00259025072203_cor2}, Liu, Meng^{Aff1, IDs00259025072203_cor3}

Metabolic characterization and radiomics-based composite model for breast cancer immune microenvironment types using ¹⁸F-FDG PET/CT

Gao, Yuan^{Aff1, Aff2}, Fu, Zijian^Aff1, Zhu, Xiaojuan, Li, Hongfeng, Yin, Lei, Wu, Caixia, Chen, Jinzhi, Chen, Yulong, Liang, Li, Ye, Jingming^{Aff2, IDs0025902507306y_cor1}, Xu, Ling^{Aff2, IDs0025902507306y_cor2}, Liu, Meng^{Aff1, IDs0025902507306y_cor3}

Diagnostic and prognostic value of quantitative ¹⁸F-FDG PET/CT metabolic parameters combined with clinical indicators in patients with locally recurrent rectal cancer

Li, Junjie, Zhou, Yin, Liu, Liu, Pang, Hua^{Aff1, IDs0026102504968y_cor1}

Clinicopathologic and metabolic variables from ¹⁸F-FDG PET/CT in the prediction of recurrence pattern in stage I–III non-small cell lung cancer after curative surgery

Jimenez Londoño, G. A.^{Aff1, IDs1214902502021y_cor1}, Pérez-Beteta, J., Amo-Salas, M., Honguero-Martinez, A. F., Pérez-García, V. M., Lucas Lucas, C., Soriano Castrejón, A. M., García Vicente, A. M.

Utility of ¹⁸F-FDG PET/CT metabolic parameters on post-transplant lymphoproliferative disorder diagnosis

Zhang, Guoying^{Aff1, Aff2}, shen, Jie, Hu, Tianpeng, Zheng, Wei, Jia, Qiang, Tan, Jian, Meng, Zhaowei^{Aff1, Aff4, IDs12149025020169_cor1}

The Imaging Value of ¹⁸F-FAPI PET/CT in Sorafenib-Induced Cardiac Dysfunction in Patients with Hepatocellular Carcinoma: Compared with ¹⁸F-FDG PET/CT

Luo, Yingqi^Aff1, Yang, Qingqi^Aff2, Qin, Xiaowen, Yu, Boyang, Jiang, Shengnan, Liu, Ying^{Aff1, IDs11307025020054_cor1}

Leveraging machine learning with dynamic 18F-FDG PET/CT: integrating metabolic and flow features for lung cancer differential diagnosis

Yao, Zhiheng^Aff1, Wang, Yubo^Aff2, Wu, Yaping, Zhou, Jinpeng, Dang, Na, Wang, Meiyun, Liang, Ying^{Aff2, IDs00259025072310_cor1}, Sun, Tao^{Aff1, IDs00259025072310_cor2}

The relation between stress-related neural activity assessed by brain ¹⁸F-FDG-PET/CT and cardiovascular outcomes: a systematic review and meta-analysis

Zhang, Xinyuan, Li, Hengxin, Niu, Xiaoyu, Fu, Hang, Xu, Rong, Xu, Ke, Yuan, Weifeng, Xu, Ting, Zeng, Jiangyao, Zhou, Ziqi, Song, Yu, Zhang, Suming, Guo, Yingkun, Huang, Shan^{Aff1, IDs0025902507217y_cor1}, Xu, Huayan^{Aff1, Aff2, IDs0025902507217y_cor2}

Analysis of the best time-point for 18F-FDG PET/CT delayed imaging in patients of small colorectal cancer liver metastasis with hypothyroidism based on diagnostic efficacy and image standardized uptake values

Pei, Yusong, Tong, Yanan, Wang, Zhiguo, Qiao, Xinxin, Liu, Yanqing, Zhang, Guoxu^{Aff1, IDs12149025020454_cor1}

Meta-analysis of [¹⁸F]FDG-PET/CT in pulmonary sarcoidosis

Donnelly, Ryan^{Aff1, Aff2, IDs00330024109494_cor1}, McDermott, Michael, McManus, Gerry, Franciosi, Alessandro N.^{Aff1, Aff2}, Keane, Michael P.^{Aff1, Aff2}, McGrath, Emmet E.^{Aff1, Aff2}, McCarthy, Cormac^{Aff1, Aff2, IDs00330024109494_cor2}, Murphy, David J.^{Aff1, Aff2, IDs00330024109494_cor3}

The Role of Serum Thyroglobulin Doubling Time in Predicting Recurrences/Metastasis on ¹⁸F-FDG PET/CT and Prognosis of Differentiated Thyroid Cancer Patients with High Thyroglobulin and Negative Whole-Body Radioactive Iodine Scintigraphy

Phuong, Nguyen Thi, Son, Mai Hong, Ha, Nong Thanh, Linh, Chu Khanh, Ha, Le Ngoc^{Aff1, IDs13139025009126_cor1}

A PET/CT-based 3D deep learning model for predicting spread through air spaces in stage I lung adenocarcinoma

Zheng, Cheng^Aff1, Cai, Yujie^Aff1, Miao, Jiangfeng, Zheng, BingShu, Gao, Yan, Shen, Chen, Bao, ShanLei, Tan, ZhongHua, Sun, ChunFeng^{Aff1, IDs12094025038709_cor1}

Factors predicting advanced disease in patients with incidentally detected gallbladder cancer: when to advise ¹⁸F-FDG PET-CT?

Sarswat, Sulochana^Aff1, Singhal, Abhinav^{Aff1, IDs4033602400671y_cor1}, Sharma, Jyoti, Kumar, Akash, Das, Kalpa Jyoti